Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with CF

OBJECTIVES: The impressive improvements of CFTR function by elexacaftor/tezacaftor/ivacaftor (ETI) result in changes in the detection frequencies of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA). We assessed determinants of the response to ETI with regards to SA and PA detection frequencies as documented in the German CF Registry for people with CF (pwCF)

• Dittrich, A. M.
• Sieber, S.
• Naehrlich, L.
• Burkhart, M.
• Hafkemeyer, S.
• Tümmler, B.